DURHAM, N.C.--(BUSINESS WIRE)--Nov. 1, 2007--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today the results from its Special Meeting of Stockholders, held on October 31, 2007. The Company’s stockholders approved the proposal to exchange 140,186 shares of Series A Exchangeable Preferred Stock, issued and sold to the Warburg Pincus Private Equity IX Fund in July 2007, into 14,018,600 shares of common stock.
